In a recent article at the News & Observer, the newspaper serving Raleigh, North Carolina, Dr. Susanne B. Haga writes about the current lack of participation in clinical trails that is currently slowing down the discovery and development in the drug industry. She focuses specifically on cancer trials, which currently only have 3% of adult cancer patients participation. As for other clinical trials, only 1/2 of them are meeting specific patient trial goals. May trials go undone, leaving many medical questions up in the air.
How do you feel about the current state of patient recruitment in clinical trials?
Web Seminar
Title: Offshoring to Emerging Countries: Navigating Uncertain Waters
Date: Thursday, January 21, 2010
Time: 2:00 PM - 3:00 PM EST
Mention priority code: P1500W2BlogTwitter
Presented by:
Jacquie Mardell
Sr Director Clinical Operations
Metabolex
Sign up for the complimentary webinar here.
Date: Thursday, January 21, 2010
Time: 2:00 PM - 3:00 PM EST
Mention priority code: P1500W2BlogTwitter
Presented by:
Jacquie Mardell
Sr Director Clinical Operations
Metabolex
Sign up for the complimentary webinar here.
Blog Archive
-
▼
2009
(203)
-
►
December
(29)
- Complimentary Web Seminar: Offshoring to Emerging ...
- Happy Holidays from Partnerships in Clinical Trial...
- Complimentary Web Seminar: Offshoring to Emerging ...
- Central Labs Spotlight: Craig Lipset , Pfizer
- Attend Central Labs on us!
- Partnerships keynote speaker Ethan Zohn's cancer i...
- Attend Partnerships in Clinical Trials as a Guest ...
- Central Labs Spotlight: Guy Mascaro and Linda Sull...
- Covance expanding in Asia-Pacific
- How open innovation could reinvigorate the pharmac...
- Would you like to guest blog from Partnerships in ...
- Rules-Based Medicine and Psynova Neurotech Announc...
- Thank you from Partnerships in Clinical Trials Asi...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Tail...
- Partnerships in Clinical Trials Asia Pacific: The ...
- Partnerships in Clinical Trials Asia Pacific: How ...
- Partnerships in Clinical Trials Asia Pacific: Regi...
- Partnerships in Clinical Trials Asia Pacific: A Da...
- Partnerships in Clinical Trials Asia Pacific: Acce...
- Partnerships in Clinical Trials Asia Pacific: Stra...
- Partnerships in Clinical Trials Asia Pacific: Find...
- Partnerships in Clinical Trials Asia Pacific: Outs...
- Partnerships in Clinical Trials Asia Pacific: Asia...
- Partnerships in Clinical Trials Asia Pacific: New ...
- Partnerships in Clinical Trials Asia Pacific: Welc...
- Central Labs Speaker Profile: Dr. James D Watson
-
►
November
(9)
- Covance Partners with RBM to Extend Biomarker Offe...
- Forced Degradation Brochure Now Available
- Call for Bloggers: Attend Partnerships in Clinical...
- Forced Degradation Forum Brochure Available
- Contract Research Remains Strong According to F&S ...
- A new way to find potential clinical trial partici...
- Partnerships In Clinical Trials Expands Its Global...
- Malaria vaccine trail to begin in east Africa
- Florida Senator wants to see clinical trial expens...
-
►
October
(8)
- PPD Makes Significant Inroad into China Biotech wi...
- Studies may be failing to show adverse effects of ...
- Genzyme begins Phase 3 clinical trial
- Amarin Appoints Medpace as CRO for Two Phase 3 Car...
- Top 5 Clinical Trial Partnering in Asia Pacific Qu...
- Kansas Cancer Center to Join Clinical Trials
- New guidance draft document for REMS
- Adaptive Clinical Trials Benefit Smaller Laborator...
-
▼
August
(16)
- Pfizer and Private Team Access Launch New Patient ...
- The lack of participation in clincial trials
- Official Call For Papers: Oncology Clinical Trial...
- Outsourcing of clinical trials expected to rise by...
- Pfizer to create online networking site for clinic...
- Medicare's Stance on Clinical Trials
- Medicare's Stance on Clinical Trials
- Stem cells for the heart in clinical trial
- Biopharma in India is Surging
- goBalto, Matchmaking for CROs and Drug Developers
- India Expected to Take Larger Share of Outsourcin...
- Clinical Trial Cost & Contract Management Agenda F...
- Web Seminar: REMS, EU-RMP and FDAAA: Navigating th...
- Repros Therapeutics Inc. halts clinical trial
- Outsourcing to grow 10% says WSHP
- USA and Europe team together to monitor clinical t...
-
►
December
(29)













0 comments:
Post a Comment